Serum Gelsolin Combined with Albumin Might Be a Promising Marker for the Intensive Care Unit-Acquired Weakness—A Pilot Study
Diagnostics · 03.03.2026 · 16 (5) · 758
DOI: 10.3390/diagnostics16050758 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 03.03.2026. Verfasst von Zoltán Horváth-Szalai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, University of Pécs Medical School, Ifjúság u. 13, 7624 Pécs, Hungary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Culture and Innovation of Hungary through the National Research, Development and Innovation Fund, University of Pécs Research Scholarship Program, University of Pécs Medical School.
Themen: Intensivpflege
Abstract (Originalsprache)
Background/Objectives: Intensive care unit-acquired weakness (ICUAW) is a frequent complication characterized by symmetrical and proximal limb muscle weakness. Its diagnosis is primarily based on clinical symptoms; however, ICUAW assessment can often be uncertain. Blood biomarkers have not yet been widely investigated for this purpose. Serum gelsolin (GSN) is synthesized by skeletal muscle cells. It plays a crucial role in binding extracellular actin filaments and pro-inflammatory cytokines. In sepsis-associated ICUAW, GSN levels might massively decrease due to their buffering activity and muscle wasting. We elucidated the predictive capacity of GSN regarding ICUAW and its additional diagnostic/prognostic potential in sepsis compared to classical parameters.
Methods
We recruited septic and non-septic ICU patients for our follow-up study. Patients were retrospectively categorized into ICUAW positive (n = 26) and negative (n = 47) groups based on their clinical characteristics. Sera were collected on the 1st, 2nd and 3rd days of ICU stay. Ambulatory patients (n = 34) served as controls. GSN levels were measured by our previously developed automated immunoturbidimetric assay. Clinical and laboratory parameters were collected from our hospital information system.
Results
Admission GSN levels were significantly reduced in ICU patients compared to controls (median: 11.60 vs. 75.99 mg/L). ICUAW positive patients had significantly lower admission GSN levels than ICUAW negative patients (median: 8.10 vs. 14.30 mg/L), and a similar tendency was observed during follow-up. GSN showed predictive capacity regarding ICUAW (ROC AUC: 0.711, p < 0.01), especially when combined with albumin (ROC AUC: 0.750, p < 0.01). The combination of admission GSN, albumin, and procalcitonin demonstrated significant diagnostic performance (ROC AUC: 0.803) regarding the requirement for invasive ventilation, and GSN had prognostic value for 28-day mortality as well.
Conclusions
GSN might serve as an intriguing marker in the prediction of ICUAW, especially when combined with albumin. The parallel decline of GSN and albumin could reflect the combined effects of systemic inflammation and muscle wasting seen in ICUAW.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, University of Pécs Medical School, Ifjúság u. 13, 7624 Pécs, Hungary.
- Molecular Medicine Research Group, Szentágothai Research Center, University of Pécs, Ifjúság u. 20, 7624 Pécs, Hungary.
- Department of Anesthesiology and Intensive Therapy, University of Pécs Medical School, Ifjúság u. 13, 7624 Pécs, Hungary.
- Department of Biophysics, University of Pécs Medical School, Szigeti u. 12, 7624 Pécs, Hungary.
ORCID-Profile: Zoltán Horváth-Szalai, Balázs Szirmay, Dániel Ragán, Attila Miseta
Förderung
- Ministry of Culture and Innovation of Hungary through the National Research, Development and Innovation Fund
- University of Pécs Research Scholarship Program
- University of Pécs Medical School
Zitieren
APA
Horváth-Szalai, Z., Molnár, T., Rostás, I., Szirmay, B., Ragán, D., Kustán, P., Papp, I., Huber, T., Tóth, N., Mérei, Á., Miseta, A., Kőszegi, T., & Mühl, D. (2026). Serum Gelsolin Combined with Albumin Might Be a Promising Marker for the Intensive Care Unit-Acquired Weakness—A Pilot Study. Diagnostics, 16(5), 758. https://doi.org/10.3390/diagnostics16050758
Vancouver
Horváth-Szalai Z, Molnár T, Rostás I, Szirmay B, Ragán D, Kustán P, et al. Serum Gelsolin Combined with Albumin Might Be a Promising Marker for the Intensive Care Unit-Acquired Weakness—A Pilot Study. Diagnostics. 2026;16(5):758. doi:10.3390/diagnostics16050758
BibTeX
@article{HorvthSzalai2026,
author = {Horváth-Szalai, Zoltán and Molnár, Tihamér and Rostás, Ildikó and Szirmay, Balázs and Ragán, Dániel and Kustán, Péter and Papp, István and Huber, Tamás and Tóth, Natália and Mérei, Ákos and Miseta, Attila and Kőszegi, Tamás and Mühl, Diána},
title = {Serum Gelsolin Combined with Albumin Might Be a Promising Marker for the Intensive Care Unit-Acquired Weakness—A Pilot Study},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {5},
pages = {758},
doi = {10.3390/diagnostics16050758}
}
EUVIMED